Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?

31 Jan 2017

• By Derrick Gingery

Business time concept as a group of running businessmen and businesswomen using a giant clock to cross over a cliff as a bridge as a metaphor for schedule and appointment speed as a 3D illustration.

Related Content

Trump Takes Office, Change At US FDA Arrives With ‘Beachhead Teams’

19 Jan 2017

FDA Commissioner Candidate Gulfo Hates Breakthrough, Wants To Reevaluate User Fees

26 Jan 2017

US FDA Might Be Temporarily Headed By Ostroff As Califf Sets His Departure

05 Jan 2017

Hamburg, Sharfstein Appointments To FDA Shift Focus To Future Plans Of Career Officials

14 Mar 2009

Could Drug Price Spikes Spur ANDA Priority Reviews?

28 Jan 2016

Califf Nomination Suffers 'Pile On': What Can FDA Do To Break Logjam?

01 Feb 2016

Opioids Can't Stop Califf Confirmation

23 Feb 2016

Trump Throws Pharma A Curve Ball On The Third Day Of J.P. Morgan

12 Jan 2017

FDA Commissioner McClellan

21 Oct 2002

Trump’s HHS, CMS Leadership Choices Underscore Focus On ACA Reform

30 Nov 2016

Additional Topics

United States FDA Leadership Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.